Eton Pharmaceuticals, Inc. (ETON)
62.67
+0.05
(+0.08%)
USD |
NASDAQ |
Aug 27, 16:00
62.62
-0.05
(-0.08%)
After-Hours: 07:54
Eton Pharmaceuticals Cash from Operations (Quarterly) : 7.255M for June 30, 2026
Cash from Operations (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 7.255M |
| March 31, 2026 | 7.405M |
| December 31, 2025 | -11.55M |
| September 30, 2025 | 12.03M |
| June 30, 2025 | 7.959M |
| March 31, 2025 | 2.09M |
| December 31, 2024 | -0.765M |
| September 30, 2024 | 2.952M |
| June 30, 2024 | 1.255M |
| March 31, 2024 | -2.473M |
| December 31, 2023 | 0.387M |
| September 30, 2023 | 0.873M |
| June 30, 2023 | 7.103M |
| March 31, 2023 | -1.548M |
| December 31, 2022 | 2.84M |
| September 30, 2022 | -1.703M |
| June 30, 2022 | 2.461M |
| March 31, 2022 | 1.223M |
| Date | Value |
|---|---|
| December 31, 2021 | -5.117M |
| September 30, 2021 | -2.95M |
| June 30, 2021 | -0.369M |
| March 31, 2021 | 3.715M |
| December 31, 2020 | -7.182M |
| September 30, 2020 | -5.094M |
| June 30, 2020 | -2.853M |
| March 31, 2020 | -7.217M |
| December 31, 2019 | -3.848M |
| September 30, 2019 | -3.215M |
| June 30, 2019 | -4.196M |
| March 31, 2019 | -6.767M |
| December 31, 2018 | -1.774M |
| September 30, 2018 | -2.293M |
| June 30, 2018 | -2.228M |
| March 31, 2018 | -1.85M |
| December 31, 2017 | -1.068M |
| September 30, 2017 | -2.207M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Nektar Therapeutics | -75.77M |
| Pfizer Inc. | 835.00M |
| Elite Pharmaceuticals, Inc. | 10.07M |
| Daré Bioscience, Inc. | -6.775M |
| Liquidia Corp. | 80.24M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 0.005M |
| Cash from Financing (Quarterly) | -0.076M |
| Free Cash Flow | -0.268M |
| Free Cash Flow Per Share (Quarterly) | 0.2214 |
| Free Cash Flow to Equity (Quarterly) | 9.297M |
| Free Cash Flow to Firm (Quarterly) | 9.593M |
| Free Cash Flow Yield | -0.01% |